Long Ideas

Analysts Highlights Apple Inc. and Alibaba Group Holding Ltd as Stocks to Buy

Analysts are offering bullish views on Apple Inc. (NASDAQ:AAPL) and Alibaba Group Holding Ltd (NYSE:BABA), expressing greater confidence than consensus on both stocks.

BTIG Sets Expectations on Synergy Pharmaceuticals Inc (SGYP) Following FDA Approval

BTIG analyst Tim Chiang weighed in today on Synergy Pharmaceuticals Inc (NASDAQ:SGYP), after the drug maker reported the achievement of a milestone few biotechnology companies reach—FDA …

Oppenheimer Chimes In On Synergy Pharmaceuticals Inc (SGYP) As Trulance Launch Expected In The Coming Weeks

Yesterday after the close, the FDA granted final approval to Synergy Pharmaceuticals Inc’s (NASDAQ:SGYP) Trulance (plecanatide), for the treatment of chronic constipation. However, Synergy …

FBR Optimistic on Novavax, Inc. (NVAX) Following Management Meeting

FBR analyst Vernon Bernardino met with Novavax, Inc. (NASDAQ:NVAX) management last week to discuss fundamentals and future 2017 clinical development.

Earnings Beat: Drexel Hamilton Weighs In on International Business Machines Corp. (IBM)

In a research report published Friday, Drexel Hamilton analyst Brian White reiterated a Buy rating on shares of International Business Machines Corp. (NYSE:IBM), …

Skyworks Solutions Inc: The Best Pure-Play In The Secularly Growing RF Market

Skyworks Solutions Inc (NASDAQ:SWKS) shares are soaring today after the chip maker blew consensus estimates when it reported its first fiscal quarter results yesterday. The …

Synergy Pharmaceuticals Inc (SGYP) Shares Fall on Back of ‘Sell on the News’ Reaction; Rodman & Renshaw Bullish

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) impressed Rodman & Renshaw analyst Ram Selvaraju with the announcement yesterday evening that the biotech has attained “a milestone …

William Blair Bullish on Synthetic Biologics Inc (SYN) on Back of FDA Phase IIb/III Trial Design Approval

Synthetic Biologics Inc (NYSEMKT:SYN) revealed Wednesday, January 18th after market close that the FDA has green-lighted its Phase IIb/III adaptive trial design of …

These Two Sell-Side Analysts Boost Price Targets on Tesla Motors Inc (TSLA) and Netflix, Inc. (NFLX); Here’s Why

Two sell-side analysts are providing bullish forecasts on stock giants Tesla Motors Inc (NASDAQ:TSLA) and Netflix, Inc. (NASDAQ:NFLX).

Maxim Analyst Chimes In on Anavex Life Sciences Corp. (AVXL)

Anavex Life Sciences Corp. (NASDAQ:AVXL) shares are up 8% in Tuesday’s trading session, after the drug maker announced that the International Rett Syndrome …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts